| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Concluding remarks
|
Blaine Hollinger, F.
|
|
1989
|
87 |
3S1 |
p. S41-
1 p.
|
article
|
| 2 |
Factors influencing the immune response to hepatitis B vaccine, booster dose guidelines, and vaccine protocol recommendations
|
Blaine Hollinger, F.
|
|
1989
|
87 |
3S1 |
p. S36-S40
5 p.
|
article
|
| 3 |
Feasibility of controlling or eradicating the hepatitis B virus
|
Blumberg, Baruch S.
|
|
1989
|
87 |
3S1 |
p. S2-S4
3 p.
|
article
|
| 4 |
Hepatitis B infection in the United States
|
Kane, Mark A.
|
|
1989
|
87 |
3S1 |
p. S11-S13
3 p.
|
article
|
| 5 |
Hepatitis B vaccination of neonates and children
|
Tong, Myron J.
|
|
1989
|
87 |
3S1 |
p. S33-S35
3 p.
|
article
|
| 6 |
Immunogenicity of a yeast-derived hepatitis B vaccine in hemodialysis patients
|
Bruguera, Miguel
|
|
1989
|
87 |
3S1 |
p. S30-S32
3 p.
|
article
|
| 7 |
Introduction
|
Blaine Hollinger, F.
|
|
1989
|
87 |
3S1 |
p. S1-
1 p.
|
article
|
| 8 |
Protective efficacy of a recombinant deoxyribonucleic acid hepatitis B vaccine in institutionalized mentally handicapped clients
|
Van Damme, Pierre
|
|
1989
|
87 |
3S1 |
p. S26-S29
4 p.
|
article
|
| 9 |
Publisher's note
|
|
|
1989
|
87 |
3S1 |
p. iii-
1 p.
|
article
|
| 10 |
Seroepidemiology of Hepatitis B virus infection in the United States 1976 to 1980
|
M. McQuilland, Geraldine
|
|
1989
|
87 |
3S1 |
p. S5-S10
6 p.
|
article
|
| 11 |
Summary of safety and efficacy data on a yeast-derived hepatitis B vaccine
|
André, Francis E.
|
|
1989
|
87 |
3S1 |
p. S14-S20
7 p.
|
article
|
| 12 |
Vaccination against hepatitis B in homosexual men
|
Goilav, Christian
|
|
1989
|
87 |
3S1 |
p. S21-S25
5 p.
|
article
|
Journal description